Quiz

Death risk increased by how much with a bipolar disorder diagnosis?

02/26/2024

Sign Up

Psych Congress Network Newsletter

Recent Stories

News

Several Treatments Effective in Youth ADHD, but Evidence Strongest for Medication

05/31/2024

Jolynn Tumolo

While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.

While treatments that improve...

05/31/2024

Psych Congress Network

Sponsored

Join Dr. Roger McIntyre on June 6th virtually to learn about innovations in Schizophrenia. Dr. McIntyre is a paid consultant for Bristol Myers Squibb, the event sponsor.

05/31/2024

Psych Congress Network

Q&As

Unlocking the Power of Ketamine With Sandhya Prashad, MD

05/30/2024

Featuring Sandhya Prashad, MD

Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.

Sandhya Prashad, MD, discusses...

05/30/2024

Psych Congress Network

News

Patients With Anhedonia More Severely Affected Than Other Patients With MDD

05/30/2024

Evi Arthur

Patients with major depressive disorder and anhedonia may have more severe depressive symptoms than patients with MDD and no/low anhedonia (other-MDD), according to results presented via poster at Psych Congress Elevate.

Patients with major depressive...

05/30/2024

Psych Congress Network

Q&As

Helping Patients Navigate the Stimulant Shortage and Other Challenges in Adult ADHD

05/28/2024

Featuring Lenard A. Adler, MD

In Part 2 of this interview Lenard A. Adler, MD, explains the root causes behind the stimulant medication shortage as well as non-pharmacological strategies clinicians can share with their Adult ADHD patients.

In Part 2 of this interview...

05/28/2024

Psych Congress Network

Death risk increased by how much with a bipolar disorder diagnosis?

Sign Up

Recent Stories

Specialties

Events

Year Round Education

HMP Global Products